| Nom |
2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate |
| Nom anglais |
2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentonic acid gamma-lactone 3,5-dibenzoate; 2-Deoxy-2,2-difuoro-D-Ribofuranofuranose-3,5-dibenzoate; 3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-erythropentane-1,4-lactone; Intermediate of Capecitabine; capecitabine intermediate; 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-difluoropentofuranos-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentofuranous-1-ulose-3,5- dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate; 3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D- erythropentane-1,4-lactone; 4,4-difluoro-5-oxo-2-{[(phenylcarbonyl)oxy]methyl}tetrahydrofuran-3-yl benzoate (non-preferred name); 2'-Deoxy-2',2',-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoate; 2'-Deoxy-2',2'-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoate; T6; 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoate; 4,4-difluoro-2-((3-fluorobenzoyloxy)methyl)-5-(methylsulfonyloxy)tetrahydrofuran-3-yl 3-fluorobenzoate; 3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-ribofuran-1-ulose; T6:2-deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate |
| Formule moléculaire |
C19H14F2O6 |
| Poids Moléculaire |
376.3077 |
| InChI |
InChI=1/C19H14F2O6/c20-19(21)15(27-17(23)13-9-5-2-6-10-13)14(26-18(19)24)11-25-16(22)12-7-3-1-4-8-12/h1-10,14-15H,11H2 |
| Numéro de registre CAS |
122111-01-7 |
| Structure moléculaire |
|
| Densité |
1.41g/cm3 |
| Point d'ébullition |
437.2°C at 760 mmHg |
| Indice de réfraction |
1.57 |
| Point d'éclair |
210.5°C |
| Pression de vapeur |
7.61E-08mmHg at 25°C |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
